the company’s first product for adult B-cell Non-Hodgkin Lymphoma (B-NHL). Benchmarked to international standards, this personalised therapy is for adults with relapsed B-NHL, said Immuneel ...

A 17-year-old schoolgirl has died from suspected sepsis just seven days after completing cancer treatment for stage four Hodgkin's lymphoma. Hannah Riddell finished school at Ashington Academy ...

A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer risk by activating Th2 immunity. These results indicate that Th2 cell ...

Stage IV Hodgkin's or non ... Lesions show elevated T2 signal, and sometimes isointense or hyperintense T1 signal, most likely due to abundant intracellular protein. Lesions that may mimic ...

However, metformin did not protect Black patients against squamous cell carcinoma specifically. “This study strengthens the evidence supporting metformin's potential as a protective agent ...

"The complete response rate, consistent treatment response and safety profile across multiple clinical studies to date with HyBryte™ has been exciting to see," noted Dr. Kim, Principal ...

In B, contrast-enhanced chest CT scan performed 70 days after the initial scan, showing an increase in lesion size, as well as central ... Primary pulmonary Hodgkin's lymphoma: A rare etiology ...

According to the leukocyte common antigen-positive and CD20-positive immunohistochemistry, the pathologic diagnosis was non-Hodgkin's lymphoma ... of multicentric lesions and the staging of ...